A general enabeling technology for manufacturing pure nanoparticles

Organization:Pharmaceutics International Inc., MD, US
I.P. Brief:A novel enabling technique to manufacture nanospheres made entirely from a single material such as carrier-free drug nanoparticles. For example, nanoparticles with 10-200 nanometers diameter can be prepared to improve solubility and dissolution. Surface-modified particles with specific receptor agonists enhances site specific targeting to tissues and cells
Keywords:enabling technology, nanomedicine, manufacturing of nanoparticles, nanomaterials, drug targeting, cancer treatment, hormonal therapy, enhanced absorption
Primary Industry:Pharma & Biotech
Specific Market:Advanced therapy for cancer, hormonal disorders, rhematoid arthritis, pain

Full IP Descriptions available on-site.


HIGHLIGHTS

Merck
Corporate Symposium

Harvard OTD
Partner Sponsor

2008 Corporate Presentations

Air Products
Boeing
BP
Cabot
Honda
Kodak
Medtronic
Merck
  • BASF
  • Genzyme
  • Lockheed Martin
  • Sanyo

Event Sponsors

Univalor
AzTE
Jackson Walker

Collocated Events

June 1-5, 2008
Nanotech 2008
Clean Technology 2008
BioNano 2008

Press Sponsor

Business Wire

Commercialization Partner

BusinessWeek

Media Sponsors

(joint with Nanotech 2008) Nature
Science
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network
piribo

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect